Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia
- PMID: 22148860
- PMCID: PMC3269516
- DOI: 10.1037/a0026466
Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia
Abstract
The catechol-O-methyltransferase (COMT) val158met polymorphism has received attention in schizophrenia due to its role in prefrontal dopamine catabolism. Given the rich dopaminergic innervations of the olfactory bulb and the influence of dopamine on the transmission of olfactory signals, the authors examined the influence of COMT genotype status on the olfactory processing impairment observed in schizophrenia. The University of Pennsylvania Smell Identification Test was administered unirhinally to individuals with schizophrenia (n = 42) and a demographically matched sample of healthy controls (n = 30). Individuals were genotyped for the COMT val158met polymorphism. A statistically significant interaction of diagnosis and COMT genotype was observed, such that schizophrenia heterozygotes and Met homozygotes showed impaired odor identification accuracy relative to Val158 homozygotes. These findings could not be explained by factors such as antipsychotic medication status, clinical symptomatology, or demographic and illness characteristics. Notably, the schizophrenia Val158 homozygotes' odor identification performance was comparable to that of the control group. These data indicate that odor identification impairments observed in schizophrenia are influenced by the COMT val158met polymorphism. This relationship is consistent with specific dopaminergic modulation of primary olfactory sensory afferents, rather than a broader effect on cognitive processes. Future studies that examine the olfactory processing deficit in schizophrenia with respect to other olfactory measures and COMT haplotypes is warranted.
Figures
Similar articles
-
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.Brain. 2006 Feb;129(Pt 2):399-410. doi: 10.1093/brain/awh702. Epub 2005 Dec 5. Brain. 2006. PMID: 16330500
-
COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.Schizophr Res. 2016 May;173(1-2):94-100. doi: 10.1016/j.schres.2016.03.019. Epub 2016 Mar 24. Schizophr Res. 2016. PMID: 27021555 Free PMC article.
-
Association of catechol-O-methyltransferase Val(108/158) Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.Psychiatry Res. 2016 Aug 30;242:271-276. doi: 10.1016/j.psychres.2016.04.029. Epub 2016 Apr 14. Psychiatry Res. 2016. PMID: 27315458
-
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.Int J Neuropsychopharmacol. 2016 Apr 29;19(5):pyv132. doi: 10.1093/ijnp/pyv132. Print 2016 May. Int J Neuropsychopharmacol. 2016. PMID: 26745992 Free PMC article. Review.
-
Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.CNS Drugs. 2007;21(7):535-57. doi: 10.2165/00023210-200721070-00002. CNS Drugs. 2007. PMID: 17579498 Review.
Cited by
-
International consensus statement on allergy and rhinology: Olfaction.Int Forum Allergy Rhinol. 2022 Apr;12(4):327-680. doi: 10.1002/alr.22929. Int Forum Allergy Rhinol. 2022. PMID: 35373533 Free PMC article. Review.
-
Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.Schizophr Bull. 2014 Jan;40(1):50-9. doi: 10.1093/schbul/sbt049. Epub 2013 May 2. Schizophr Bull. 2014. PMID: 23641047 Free PMC article.
-
Evidence of COMT dysfunction in the olfactory bulb in Parkinson's disease.Acta Neuropathol. 2025 Mar 1;149(1):21. doi: 10.1007/s00401-025-02861-y. Acta Neuropathol. 2025. PMID: 40024917 Free PMC article.
-
Olfactory deficits and psychosis-spectrum symptoms in 22q11.2 deletion syndrome.Schizophr Res. 2018 Dec;202:113-119. doi: 10.1016/j.schres.2018.07.012. Epub 2018 Jul 11. Schizophr Res. 2018. PMID: 30007867 Free PMC article.
-
Exploring causal mechanisms of psychosis risk.Neurosci Biobehav Rev. 2024 Jul;162:105699. doi: 10.1016/j.neubiorev.2024.105699. Epub 2024 May 6. Neurosci Biobehav Rev. 2024. PMID: 38710421 Free PMC article. Review.
References
-
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4. Washington, DC: Author; 2000. text revision.
-
- Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS) Iowa City, IA: The University of Iowa; 1984a.
-
- Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS) Iowa City, IA: The University of Iowa; 1984b.
-
- Anholt RRH, Mackay TFC. Principles of behavioral genetics. Amsterdam: Academic; 2010. Genetics of Olfaction and Taste; pp. 207–230.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous